NVIDIA Corporation (NVDA19)
Thailand Exchange · Thailand · prices in THB · close of 22 Oct 2026
Key indicators
| Last close | THB 29.25 |
|---|---|
| 52-week range | 21.50 – 32.75 |
| Return, 1 month / 3 months | −3.3% / +4.6% |
| Return, 1 year / 3 years | +23.1% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 37.7% |
| Worst drawdown (1 year) | -18.9% |
| Average daily value traded | 2.47M THB |
| Dividend yield | 6.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NVIDIA Corporation designs and supplies graphics processing units and related hardware and software. Its products serve gamers through GeForce graphics cards, professional users through workstation graphics, and data centers running artificial intelligence and high-performance computing workloads. The company also provides networking products and software platforms for developers and enterprises. NVIDIA is based in Santa Clara, California, in the United States, and its chips are used by computer makers, cloud providers and research institutions around the world.
NVIDIA Corporation trades under the code NVDA19 on the Thailand Exchange in Thailand, with its price quoted in Thai baht (THB). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NVIDIA Corporation (NVDA19) trades on the Thailand Exchange in Thailand. It last closed at THB 29.25 on 22 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 372 of 1,349 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 23.1% and over the last three months it rose 4.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Thailand Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.7% | ||
| From 52-week high | -10.0% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 4.6% | ||
| 6-month return | 12.7% | ||
| 12-month return, skipping the last month | 27.3% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.9% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.47M THB | ||
| Zero-volume days | 3.3% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.6% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | −3.3% |
| 3 months | +4.6% |
| 6 months | +12.7% |
| 1 year | +23.1% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 29.84 / 26.66 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.72 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | USD 0.0276 |
| 4 Jun 2026 | USD 0.0276 |
| 11 Mar 2026 | USD 0.0010 |
| 4 Dec 2025 | USD 0.0010 |
| 11 Sep 2025 | USD 0.0010 |
| 11 Jun 2025 | USD 0.0011 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Thailand Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.